Azopt Suspension/ Drops
Product Images NDC 66758-085

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azopt (NDC 66758-085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brinzolamide Structural Formula (Azopt 01)

Chemical structure diagram of brinzolamide, the active ingredient in Azopt 10 mg/mL ophthalmic suspension. The structure shows atoms and bonds of the molecule, including amine, sulfonamide, and other functional groups.*

FDA Label Image

France-carton (France Carton)

Packaging label for Azopt (brinzolamide ophthalmic suspension) 1%, a 10 mL sterile ophthalmic suspension. The label includes the brand and generic names, NDC 66758-085-70, usage warnings, storage instructions, and manufacturer information for Sandoz Inc. The label also features a blue and orange drop graphic and a barcode.*

FDA Label Image

Switzerland-carton (Switzerland Carton)

Azopt (brinzolamide ophthalmic suspension) 1% is an ophthalmic suspension in a 10 mL sterile bottle. The packaging label displays the proprietary name Azopt prominently with the generic name brinzolamide. The label includes storage instructions, dosage warnings, and a barcode. It is manufactured by Sandoz Inc for Alcon Laboratories, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.